Literature DB >> 971700

Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.

K O'Malley, M Velasco, J Wells, J McNay.   

Abstract

A study, using non-invasive techniques, was carried out in ten patients with essential hypertension to examine the mechanism of the hypotensive effect of propranolol when used in combination with a potent vasodilator antihypertensive - minoxidil. The hypotensive effect of minoxidil, a mean (+/- SEM) decrease of 42.4 +/- 4.3 mm Hg, was accompanied by a marked increase in heart rate, cardiac index and plasma renin activity and a significant decrease in total peripheral resistance, limb vascular resistance and pre-ejection period. Addition of propranolol further reduced mean arterial pressure by an average of 12.9 +/- 2.0 mm Hg. Propranolol returned cardiac index to control values and total peripheral resistance index rose but not to control levels. Plasma renin activity was significantly reduced by propranolol. By multiple regression analysis no correlation was found between propranolol-induced decrease in mean arterial pressure and changes in cardiac index, total peripheral resistance index or plasma renin activity. Quantitatively, the reduction in cardiac index observed probably accounted for the hypotensive effect of propranolol. The role of plasma renin activity reduction in the hypotensive effect of propranolol in this situation remains to be clarified. The findings in the present study were consonant with the known actions of vasodilator antihypertensive agents and propranolol and indicate the applicability of non-invasive methodology to the investigation of cardiovascular drugs in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971700     DOI: 10.1007/BF00606548

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  A method for achieving blood pressure control expeditiously with oral minoxidil.

Authors:  K O'Malley; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

Review 2.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

5.  Effect of practolol on blood pressure and renin release in man.

Authors:  M D Esler
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

6.  Combined dihydralazine and propranolol in the treatment of hypertension.

Authors:  M Katila; M H Frick
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-12

7.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

8.  Letter: Beta receptors and renin release.

Authors:  A Amery; L Billiet; R Fagard
Journal:  N Engl J Med       Date:  1974-01-31       Impact factor: 91.245

9.  Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man.

Authors:  W S Harris; C D Schoenfeld; A M Weissler
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

10.  Beta-blockers and plasma renin activity in hypertension.

Authors:  G S Stokes; M A Weber; I R Thornell
Journal:  Br Med J       Date:  1974-01-12
View more
  6 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Effect of clonidine on sympathetic nervous activity in hydralazine-treated hypertensive patients.

Authors:  M Velasco; H Bertoncini; E Romero; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

3.  Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

4.  Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.

Authors:  M Chaffman; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

5.  Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.

Authors:  M Velasco; E Romero; H Bertoncini; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

6.  Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.

Authors:  M Velasco; A Urbina-Quintana; J Morillo; H Vizcarrondo; A Ramirez; E Hernández; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.